MEDICHEM USA LLC

General

Total Cases1

Active Cases1

Patents--

CourtsD. New Jersey

TypeOperating Company

Elite Ratings

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
09/16/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. and the Honorable Ann Marie Donio, U.S.M.J. Regarding Eugia's Motion for Summary Judgment re [270] Letter,,. (CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/16/2024) Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. and the Honorable Ann Marie Donio, U.S.M.J. Regarding Eugia's Motion for Summary Judgment re [270] Letter,,. (CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/16/2024)
09/13/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	Letter from R Touhey Myer re Eugua Defendants' Motion for Summary Judgment re 268 Order,. (Attachments: # [1] Exhibit Y, # [2] Exhibit Z)(MYER, R)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/13/2024) Letter from R Touhey Myer re Eugua Defendants' Motion for Summary Judgment re 268 Order,. (Attachments: # [1] Exhibit Y, # [2] Exhibit Z)(MYER, R)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/13/2024)
09/13/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	Transcript of Telephonic Discovery and Status Conference held on 9/11/2024, before Judge Donio. Court Reporter/Transcriber Diana Doman Transcribing, LLC (856-435-7172). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter/Transcription Agency due, but not filed, by 10/4/2024. Redacted Transcript Deadline set for 10/15/2024. Release of Transcript Restriction set for 12/12/2024. (js) (Entered: 09/13/2024) Transcript of Telephonic Discovery and Status Conference held on 9/11/2024, before Judge Donio. Court Reporter/Transcriber Diana Doman Transcribing, LLC (856-435-7172). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter/Transcription Agency due, but not filed, by 10/4/2024. Redacted Transcript Deadline set for 10/15/2024. Release of Transcript Restriction set for 12/12/2024. (js) (Entered: 09/13/2024)
09/11/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	TEXT ORDER: As set forth on the record on September 11, 2024, Eugia shall file by no later than September 13, 2024 a letter to the District Judge in response to Plaintiffs' letter [D.I. 265] regarding Eugia's motion for summary judgment. SO ORDERED by Magistrate Judge Ann Marie Donio on 9/11/2024. (slc) (Entered: 09/11/2024)
09/11/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	Minute Entry for proceedings held before Magistrate Judge Ann Marie Donio: Telephonic Discovery and Status Conference held on 9/11/2024. Order to be entered. (Court Reporter, Court Conference Line) (sb) (Entered: 09/11/2024)
09/10/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	Exhibit to [265] Letter,, --Exhibit A-- by MYLAN IRELAND LIMITED, MYLAN SPECIALTY L.P., THERAVANCE BIOPHARMA IRELAND LIMITED, THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC.. (CALMANN, ARNOLD) (Entered: 09/10/2024)
09/10/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. and the Honorable Ann Marie Donio, U.S.M.J. Regarding Eugia's Motion for Summary Judgment re [258] MOTION for Summary Judgment of Non-Infringement. (CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/10/2024) Letter from Arnold B. Calmann, Esq. to the Honorable Karen M. Williams, U.S.D.J. and the Honorable Ann Marie Donio, U.S.M.J. Regarding Eugia's Motion for Summary Judgment re [258] MOTION for Summary Judgment of Non-Infringement. (CALMANN, ARNOLD)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/10/2024)
09/05/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	DECLARATION of Timothy H. Kratz re [258] MOTION for Summary Judgment of Non-Infringement by AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC. (MYER, R) (Entered: 09/05/2024)
09/05/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney JAMES S. RICHTER terminated. (RICHTER, JAMES) (Entered: 09/05/2024)
09/05/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	CLERK'S OFFICE QUALITY CONTROL MESSAGE - The Declaration [258-1] submitted by R TOUHEY MYER, Esq. on 9/4/2024 contains an improper signature. Only the filing user is permitted to sign electronically filed documents with an s/. PLEASE RESUBMIT THE DOCUMENT WITH A PROPER ELECTRONIC SIGNATURE. This submission will remain on the docket unless otherwise ordered by the court. (js) (Entered: 09/05/2024)